Elliot Ginchansky
Allergy & Immunology · Dallas, TXNPI 1962401471
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AstraZeneca at 24.4% of the total. Reporting peaked in 2019 at $1,913 and has fallen 92.3% since, to $147 in 2022. That places this record below the midpoint for allergy & immunology clinicians in TX, where the typical reported total is $5,878.
Across 93 payments — averaging $26.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$601
- Regeneron Healthcare Solutions, Inc.$393
- GSK$303
- Sanofi Pasteur Inc.$229
- Regeneron$204
- Kaleo, Inc.$193
- plus $543 from 10 others
Across 33 payments — averaging $14,366 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$281K
- Novartis$166K
- Genentech, Inc.$27K
What the payments were for
- Food & beverage$2,465100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 26 | $601 |
| Regeneron Healthcare Solutions, Inc. | 10 | $393 |
| GSK | 15 | $303 |
| Sanofi Pasteur Inc. | 4 | $229 |
| Regeneron | 2 | $204 |
| Kaleo, Inc. | 12 | $193 |
| Novartis | 4 | $192 |
| Covis Pharma GmbH | 5 | $84 |
| Sanofi-aventis U.S. LLC | 3 | $70 |
| Optinose US, Inc. | 4 | $65 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Alk-abello, Inc | 2 | $28 |
| Shire North American Group Inc | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Greer Laboratories, Inc. | 1 | $16 |
| Genentech USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,465 in reported general payments places this provider in the 30th percentile of 336 allergy & immunology providers in Texas.
Other allergy & immunology in Dallas
- Richard WassermanDallas$452K
- Matthew FeldmanDallas$410K
- Lara GrossDallas$171K
- Sonak DaulatDallas$72K
- Joseph WestDallas$39K
- Anil NandaDallas$35K
- Joseph DiazSan Antonio$1.1M
- Lukena KarkhanisSan Antonio$377K
- Paul VigoAustin$304K
- Neha ReshamwalaAustin$303K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.